Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1996-09-27
1999-09-14
Fonda, Kathleen K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 53, 514893, A61K 3170
Patent
active
059523093
ABSTRACT:
A method for the inhibition and amelioration of alcholic liver disease in a mammal in need of such treatment by administering novel analogs of Lipid A which act as endotoxin antagonists. These antagonists compounds are found to inhibit the swift increase in alcohol metabolism which typically accompanies ingestion of alcohol and which may lead to the pathophysiological abnormalities associated with alcoholic liver disease.
REFERENCES:
patent: 5413785 (1995-05-01), Nanji
patent: 5530113 (1996-06-01), Christ et al.
Nolan, J. P. Immunological Investigations 1989, 18, 325-327. Month not available.
Nolan, J. P. Hepatology Nov. 1989, 10, 887-889.
Adachi et al. Hepatology Aug. 1994, 20, 453-460.
Adachi et al., Gastroenterology, 108:218-224, 1995.
Adachi et al., J. Hepatol., 20: 453-460, Aug. 1994.
Bone, Chest, 100:802-808, Sep. 1991.
Casteleijn et al., J. Bio. Chem., 263:2699-2703, Feb. 1988.
DeCarli et al., J. Nutr., 91:331-336, Mar. 1967.
Decker et al., Cells of the Hepatic Sinusoid, pp. 171-175, 1989.
Felver et al. Alcohol Clin. Exp. Res., 14:255-259, Mar./Apr. 1990.
Freudenberg et al., British J. of Exp. Path. 63:56-64, 1982.
Galanos et al., Proc. Nat'l. Acad. Sci., 76:5939-5943, Nov. 1979.
Goto et al., J. Pharmacol. Exp. Ther., 267:1264-1268, 1993.
Grynkiewicz et al., J. Bio. Chem., 260:3440-3450, Mar. 1985.
Hijioka et al., Mol. Pharmacol., 41:435-440, 1992.
Iwaki et al., Cells of the Hepatic Sinusoid, pp. 351-352, 1989.
Karck et al., Cells of the Hepatic Sinusoid, pp. 210-211, 1989.
Knecht et al., Mol. Pharmacol., 47:1028-1034, 1995.
Lahnborg et al., Scand. J. Gastroent., 16:481-489, 1981.
Laskin, Cells of the Hepatic Sinusoid, pp. 284-287, 1989.
Lelbach, Acta Hepatospenol., 13:321-349, Nov./Dec. 1966.
Martinez et al., Alcohol, 9:455-458, 1992.
Marzi et al., Transplant Proc., 22:2004-2005, Aug. 1990.
Mathison et al., J. Immunol., 123:2133-2143, Nov. 1979.
Mendelson et al., Anns. NY Acad. Sci., 133:828-845,1966.
Monden et al., Res. Exp. Med., 191:177-187, 1991.
Nanji et al., Ame. J. Pathol., 142:367-373, Feb. 1993.
Nolan, Hepatology, 1:458-465, 1981.
Pertoft et al., Cell Separation, 4:1-24, 1987.
Porta et al., Lab Invest., 18:352-364, 1968.
Rose et al., Inf. and Immun., 63:833-839, Mar. 1995.
Ruiter et al., Lab Invest., 45:38-45, 1981.
Shiratori et al., Cells of the Hepatic Sinusoid, pp. 313-318, 1989.
Thurman et al., Proc. 78th Falk Symposium, pp. 185-203, 1995.
Thurman et al., Molecular Pharmacol., 12:156-166, 1975.
Ueno et al., Cells of the Hepatic Sinusoid, 2:293-296, 1989.
Van Bossuyt et al., Cell Tiss. Res., 251:205-215, 1988.
Vogel et al., J. Immunol., 124:2004-2009, Apr. 1980.
Wisse et al., Cells of the Hepatic Sinusoid, 2:1-8, 1989.
Yamada et al., Liver, 11:220-224, 1991.
Yuki et al., Biochem. J., 186:119-126, 1980.
Christ William J.
Lewis Michael D.
Rossignol Daniel P.
Thurman Ronald G.
Eisai Company Ltd.
Fonda Kathleen K.
LandOfFree
Method for treating alcoholic liver disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating alcoholic liver disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating alcoholic liver disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1509802